Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.79% |
| 3 | Consumer Discretionary | 12.36% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1601
Emergent Biosolutions
EBS
$358M
| $4.4M | 0.01% |
689,647
-70,600
| -9% | -$404K |
2023 Q4
6 quarters
|
|
1602
DELISTED
Heritage Commerce
HTBK
| $4.38M | 0.01% |
441,500
+120,000
| +37% | +$1.1M |
2021 Q4
14 quarters
|
|
1603
iShares MSCI EAFE Small-Cap ETF
SCZ
$12.8B
| $4.38M | 0.01% |
+60,300
| New | +$4.08M |
2025 Q2
0 quarters
|
|
1604
Euroseas
ESEA
$502M
| $4.38M | 0.01% |
97,978
-600
| -0.6% | -$21.9K |
2013 Q2
48 quarters
|
|
1605
First Trust Managed Municipal ETF
FMB
$1.93B
| $4.37M | 0.01% |
87,792
+36,092
| +70% | +$1.8M |
2023 Q4
6 quarters
|
|
1606
Shinhan Financial Group
SHG
$35.3B
| $4.37M | 0.01% |
96,800
-145,200
| -60% | -$5.53M |
2024 Q3
3 quarters
|
|
1607
Columbia Sportswear
COLM
$2.88B
| $4.37M | 0.01% |
71,502
+26,100
| +57% | +$1.68M |
2025 Q1
1 quarter
|
|
1608
Investors Title Co
ITIC
$546M
| $4.36M | 0.01% |
20,647
-3,200
| -13% | -$718K |
2013 Q3
47 quarters
|
|
1609
iShares iBonds Dec 2028 Term Corporate ETF
IBDT
$4.14B
| $4.36M | 0.01% |
171,595
-90,105
| -34% | -$2.27M |
2024 Q2
4 quarters
|
|
1610
State Street SPDR Bloomberg International Treasury Bond ETF
BWX
$1.28B
| $4.36M | 0.01% |
+185,500
| New | +$4.24M |
2025 Q2
0 quarters
|
|
1611
Harrow
HROW
$1.09B
| $4.35M | 0.01% |
142,517
-102,853
| -42% | -$2.76M |
2018 Q3
27 quarters
|
|
1612
Saic
SAIC
$5.57B
| $4.35M | 0.01% |
38,650
+20,400
| +112% | +$2.32M |
2025 Q1
1 quarter
|
|
1613
Skyward Specialty Insurance
SKWD
$2.66B
| $4.35M | 0.01% |
75,300
+12,600
| +20% | +$727K |
2024 Q2
4 quarters
|
|
1614
Smithfield Foods
SFD
$7.28B
| $4.35M | 0.01% |
184,900
+72,100
| +64% | +$1.59M |
2025 Q1
1 quarter
|
|
1615
YieldMax Universe Fund of Option Income ETFs
YMAX
$367M
| $4.34M | 0.01% |
+315,500
| New | +$4.2M |
2025 Q2
0 quarters
|
|
1616
Photronics
PLAB
$1.73B
| $4.33M | 0.01% |
229,770
+73,077
| +47% | +$1.37M |
2023 Q1
9 quarters
|
|
1617
MillerKnoll
MLKN
$1.46B
| $4.33M | 0.01% |
+222,783
| New | +$3.8M |
2025 Q2
0 quarters
|
|
1618
Lakeland Financial Corp
LKFN
$1.42B
| $4.32M | 0.01% |
70,351
-12,100
| -15% | -$702K |
2025 Q1
1 quarter
|
|
1619
iShares China Large-Cap ETF
FXI
$3.93B
| $4.32M | 0.01% |
117,600
-339,900
| -74% | -$11.9M |
2024 Q2
4 quarters
|
|
1620
Pagaya Technologies
PGY
$1.45B
| $4.31M | 0.01% |
+202,185
| New | +$2.88M |
2025 Q2
0 quarters
|
|
1621
PACCAR
PCAR
$56.9B
| $4.31M | 0.01% |
+45,316
| New | +$4.19M |
2025 Q2
0 quarters
|
|
1622
West Bancorporation
WTBA
$491M
| $4.31M | 0.01% |
219,352
+8,200
| +4% | +$159K |
2013 Q2
48 quarters
|
|
1623
Cedar Fair
FUN
$1.22B
| $4.29M | 0.01% |
141,090
-213,700
| -60% | -$7.16M |
2025 Q1
1 quarter
|
|
1624
Rogers Corp
ROG
$2.61B
| $4.28M | 0.01% |
62,500
+57,700
| +1,202% | +$3.72M |
2025 Q1
1 quarter
|
|
1625
DELISTED
American Woodmark
AMWD
| $4.27M | 0.01% |
80,001
-42,400
| -35% | -$2.4M |
2021 Q2
16 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.